Welcome to Crene Biotechnology!


Product :

AZD2014 Vistusertib

AZD2014 Vistusertib 1009298-59-2
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:AZD2014 Vistusertib Purity:98% min
CAS NO:1009298-59-2 Solubility:DMSO : ≥ 50 mg/mL (108.10 mM)
Molecular Formula:C25H30N6O3 Package:Package according to customer requirements
Molecular Weight:462.544 Storage:Store at -20℃
Quality control

Vistusertib, also known as AZD2014, is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. mTOR kinase inhibitor AZD2014 inhibits the activity of mTOR, which may result in the induction of tumor cell apoptosis and a decrease in tumor cell proliferation. mTOR, a serine/threonine kinase that is upregulated in a variety of tumors, plays an important role downstream in the PI3K/Akt/mTOR signaling pathway.



Related Prodcuts:

Tacrolimus; AZD8055; AZD8055 fumarate; OSI-027; Zotarolimus; XL388; INK 128; PP121; Desmethyl-VS-5584;  AZD-8055

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2021 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China